PHARMACYTE BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PHARMACYTE BIOTECH, INC. (PMCB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 127.50 thousand shares for the 9-month period ending 2024-01-31, per its 10-Q filed 2024-03-18.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-03-18
- PHARMACYTE BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-01-31 was 127.50K shares.
- PHARMACYTE BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-10-31 was 0.00 shares.
- PHARMACYTE BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-07-31 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2024-01-31 | 127.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | 127.50K shares derived: sum of 2 quarters · filed 2024-03-18 | 127.50K shares 10-Q · filed 2024-03-18 |
| 2023-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | 0.00 shares 10-Q · filed 2023-12-15 | |
| 2023-07-31 | 0.00 shares 10-Q · filed 2023-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |